Insight Molecular Diagnostics Inc., (NASDAQ: IMDX) shares enjoyed strong gains at first Monday, on providing a year-end business update regarding its commercial progress, its GraftAssureDx™ test kit ...
Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology company backed by major sector investor MPM BioImpact revealed in a filing on ...
Biotech shares have fallen while cash has flowed into oil stocks following the U.S.’s seizing of Venezuelan President Nicolás ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback